Volume 18; Issue 8

Nature Biotechnology

Volume 18; Issue 8
1

First draft of genome sets new industry standards

Year:
2000
Language:
english
File:
PDF, 68 KB
english, 2000
2

Rational limits on genomic patents

Year:
2000
Language:
english
File:
PDF, 63 KB
english, 2000
3

The bioweapons convention's impact on bioindustry

Year:
2000
Language:
english
File:
PDF, 64 KB
english, 2000
4

BEP Program

Year:
2000
Language:
english
File:
PDF, 72 KB
english, 2000
5

Ubiquitin/proteasome system

Year:
2000
Language:
english
File:
PDF, 72 KB
english, 2000
6

Reply to ‘Ubiquitin/proteasome system’

Year:
2000
Language:
english
File:
PDF, 72 KB
english, 2000
7

Orchid–Consortium deal

Year:
2000
Language:
english
File:
PDF, 65 KB
english, 2000
8

Singapore genome program

Year:
2000
Language:
english
File:
PDF, 65 KB
english, 2000
9

CAT's phage technology patent upheld

Year:
2000
Language:
english
File:
PDF, 65 KB
english, 2000
10

Celgene buys Signal

Year:
2000
Language:
english
File:
PDF, 65 KB
english, 2000
11

GMO roundup

Year:
2000
Language:
english
File:
PDF, 65 KB
english, 2000
12

Joint genome announcement

Year:
2000
Language:
english
File:
PDF, 109 KB
english, 2000
13

Chimp genome project

Year:
2000
Language:
english
File:
PDF, 109 KB
english, 2000
14

Cloning opera

Year:
2000
Language:
english
File:
PDF, 109 KB
english, 2000
15

NZ de facto GMO ban

Year:
2000
Language:
english
File:
PDF, 109 KB
english, 2000
16

Biopharmaceutical sector performance, 2nd quarter 2000

Year:
2000
Language:
english
File:
PDF, 109 KB
english, 2000
17

Initial public offerings, 2nd quarter 2000

Year:
2000
Language:
english
File:
PDF, 109 KB
english, 2000
18

Biotech fundraising, Q2 2000 V. Q1 2000

Year:
2000
Language:
english
File:
PDF, 84 KB
english, 2000
19

Biotech for third world

Year:
2000
Language:
english
File:
PDF, 84 KB
english, 2000
20

Changes to RAC

Year:
2000
Language:
english
File:
PDF, 84 KB
english, 2000
21

Monsanto ruling dismissed

Year:
2000
Language:
english
File:
PDF, 84 KB
english, 2000
22

Research collaborations

Year:
2000
Language:
english
File:
PDF, 84 KB
english, 2000
23

Gene targeting in Drosophila

Year:
2000
Language:
english
File:
PDF, 100 KB
english, 2000
24

Telomerase linked with cancer risk?

Year:
2000
Language:
english
File:
PDF, 100 KB
english, 2000
25

Transgenic blood suckers

Year:
2000
Language:
english
File:
PDF, 100 KB
english, 2000
26

Bacillus identity crisis

Year:
2000
Language:
english
File:
PDF, 100 KB
english, 2000
27

Lentiviruses for stable gene therapy

Year:
2000
Language:
english
File:
PDF, 100 KB
english, 2000
28

Engineering novel carotenoids

Year:
2000
Language:
english
File:
PDF, 490 KB
english, 2000
29

Peptide vaccine on display

Year:
2000
Language:
english
File:
PDF, 490 KB
english, 2000
30

Antisense targets Fas

Year:
2000
Language:
english
File:
PDF, 490 KB
english, 2000
31

Cephalosporin biosynthesis

Year:
2000
Language:
english
File:
PDF, 491 KB
english, 2000
32

Enhanced Alzheimer's diagnostics

Year:
2000
Language:
english
File:
PDF, 490 KB
english, 2000
33

Drug receptor identification

Year:
2000
Language:
english
File:
PDF, 155 KB
english, 2000
34

Generating antibody diversity

Year:
2000
Language:
english
File:
PDF, 155 KB
english, 2000
35

Protein interaction blockers

Year:
2000
Language:
english
File:
PDF, 155 KB
english, 2000
36

Stem cell purging

Year:
2000
Language:
english
File:
PDF, 155 KB
english, 2000
37

Technical Reports

Year:
2000
Language:
english
File:
PDF, 155 KB
english, 2000
38

Technical Reports

Year:
2000
Language:
english
File:
PDF, 155 KB
english, 2000
39

Review

Year:
2000
Language:
english
File:
PDF, 155 KB
english, 2000
40

Millennium and Aventis in unique pact

Year:
2000
Language:
english
File:
PDF, 65 KB
english, 2000
41

CD18 trials disappoint again

Year:
2000
Language:
english
File:
PDF, 76 KB
english, 2000
42

Genomics company formed from Framingham heart study

Year:
2000
Language:
english
File:
PDF, 70 KB
english, 2000
43

French refuse to implement biotech patent directive

Year:
2000
Language:
english
File:
PDF, 64 KB
english, 2000
44

Researchers discuss NIH's nanotechnology initiative

Year:
2000
Language:
english
File:
PDF, 62 KB
english, 2000
45

British Biotech redefines itself

Year:
2000
Language:
english
File:
PDF, 68 KB
english, 2000
46

Imaging Alzheimer's amyloid

Year:
2000
Language:
english
File:
PDF, 328 KB
english, 2000
47

A kaleidoscope of carotenoids

Year:
2000
Language:
english
File:
PDF, 100 KB
english, 2000
48

The possibilities/perplexities of stem cells

Year:
2000
Language:
english
File:
PDF, 147 KB
english, 2000
49

Biological software for materials engineering

Year:
2000
Language:
english
File:
PDF, 160 KB
english, 2000
50

Emerging themes in medicinal glycoscience

Year:
2000
Language:
english
File:
PDF, 177 KB
english, 2000
56

Targeting Alzheimer amyloid plaques in vivo

Year:
2000
Language:
english
File:
PDF, 1.12 MB
english, 2000
60

Metabolic engineering of astaxanthin production in tobacco flowers

Year:
2000
Language:
english
File:
PDF, 214 KB
english, 2000
61

Enhancement of transfection by physical concentration of DNA at the cell surface

Year:
2000
Language:
english
File:
PDF, 147 KB
english, 2000
62

Heritable gene silencing in Drosophila using double-stranded RNA

Year:
2000
Language:
english
File:
PDF, 693 KB
english, 2000
63

European patent oppositions and biotechnology

Year:
2000
Language:
english
File:
PDF, 74 KB
english, 2000
64

Recent patents in biochips

Year:
2000
Language:
english
File:
PDF, 56 KB
english, 2000
65

In silico genomes

Year:
2000
Language:
english
File:
PDF, 118 KB
english, 2000
66

People

Year:
2000
Language:
english
File:
PDF, 30 KB
english, 2000
67

New products

Year:
2000
Language:
english
File:
PDF, 363 KB
english, 2000
68

Biopharmaceutical benchmarks

Year:
2000
Language:
english
File:
PDF, 307 KB
english, 2000